Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One-year results of an uncontrolled, prospective case series

Ophthalmology

Volumn 109, Issue 8, 2002, Pages 1499-1505

  Saperstein, David A ^a,b   Rosenfeld, Philip J ^a,b   Bressler, Neil M ^a,b   Rosa Jr, Robert H ^b   Sickenberg, Michel ^a,b   Sternberg Jr, Paul ^b   Aaberg Sr, Thomas M ^b   Aaberg Jr, Thomas M ^b   Reaves, Troy A ^a,b  

^a Novartis Ophthalmics Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; EDEMA; EXTRAVASATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GEOMETRY; HEADACHE; HUMAN; INFLAMMATION; INJECTION PAIN; MALE; MULTICENTER STUDY; OCULAR HISTOPLASMOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PRURITUS; RETINA DISEASE; SAFETY; SCORING SYSTEM; SUBRETINAL NEOVASCULARIZATION; SYNCOPE; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; RETINAL DISEASES; SAFETY; SYNDROME; VISUAL ACUITY;

EID: 0036343021     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01103-X     Document Type: Article

References (24)

1. Ocular histoplasmosis
2. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States
3. Follow-up study of presumed ocular histoplasmosis syndrome
4. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial
5. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials
6. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials
7. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes
8. Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study
9. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis
10. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: Results of a pilot randomized clinical trial
11. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis
12. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis. Stability of early visual results
13. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome
14. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization
15. Corticosteroids in the treatment of ocular histoplasmosis
16. Proton-beam irradiation of subfoveal choroidal neovascular membranes in presumed ocular histoplasmosis syndrome: A case report
17. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys
18. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP Report 1
19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP Report 2
20. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
21. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study
22. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes
23. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy Report 2
24. Argon laser photocoagulation for ocular histoplasmosis. Results of a randomized clinical trial